top of page
  • Facebook
alt="syringe"

Designing Tomorrow´s Vaccines

SVF Vaccines develops vaccines and immunotherapies to prevent and treat life-threatening diseases based on technology developed at Karolinska Institute in Stockholm. Our most advanced program is a therapeutic vaccine for chronic hepatitis B and D infections, while Karolinska Institutet and the OpenCorona consortium are performing a Phase 1 study with SVF Vaccines' universal Covid-19 vaccine. Additional vaccines are in the discovery phase.

Testimonials

“SVF develops a therapeutic vaccine for chronic hepatitis B and D infection, and a prophylactic vaccine targeting both the current COVID-19 pandemic and other coronavirus infections.”

Jens Bäck

Board Member

bottom of page